Aeva Technologies, Inc. AEVA
8.94 USD +0.34 (+3.95%)
At closeNov 3, 2026, 4:39 PM EST
9.08 +0.14 +1.57%
After hours · Nov 3, 4:39 PM ET
8.71 Day range 9.11
8.52 52-week range 31.30
- YTD
- -32.68%
- 1 year
- -42.02%
Analyst view
Price target (mean) 30.00 +235.6% upside
Now 8.94
- Target (low)
- 20.00
- Target (mean)
- 30.00
- Target (high)
- 42.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.426 | -0.47 – -0.37 | -0.46 | +7.4% | 7.24M | +102.4% | 5 |
| Next quarter | -0.42 | -0.49 – -0.37 | -0.40 | -5.0% | 12.97M | +130.7% | 5 |
| Current year | -1.53 | -1.78 – -1.01 | -1.75 | +12.3% | 32.36M | +79.0% | 5 |
| Next year | -1.61 | -1.87 – -1.40 | -1.53 | -4.8% | 72.72M | +124.8% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 2026 | Goldman Sachs | Initiated | — | Neutral |
| Aug 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 11, 2026 | Amerx | Initiated | — | Hold |
| Dec 4, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 1, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 16, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 17, 2025 | Roth Capital | Maintained | Buy | Buy |
| May 15, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| May 15, 2025 | Roth Capital | Maintained | Buy | Buy |
| May 15, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 12, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 21, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 1, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Mar 21, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Mar 20, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Nov 7, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Nov 7, 2024 | Roth MKM | Maintained | Buy | Buy |
| Aug 8, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Aug 8, 2024 | Roth MKM | Maintained | Buy | Buy |
| Aug 7, 2024 | WestPark Capital | Reiterated | — | Hold |
| May 8, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Mar 19, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Mar 6, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jan 10, 2024 | Roth MKM | Maintained | Buy | Buy |
| Nov 9, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 27, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Aug 9, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 9, 2023 | Piper Sandler | Reiterated | Neutral | Neutral |